Section: DRUG METABOLISM
DESIGN AND DISCOVERY
Organizing Secretary: Chandra Prakash
Pfizer Global R&D
Eastern Point Road,?Groton, USA
|
INVITED LECTURES
|
Abstract Awaited
Chandra Prakash
Pfizer Global R&D, Eastern Point Road,?Groton,
USA
|
| Predicting Enzyme Induction and Drug-Drug
Interactions
Michael Sinz
Bristol Myers Squibb, USA
|
| Mitigating the reactivity of acyl glucuronides
in a NEPi discovery programme
Kevin Beaumont
Senior Director and Head of Discovery PDM, Pfizer
Global Research and Development, Sandwich Laboratories,
UK
|
| Understanding the Biochemical Basis of
Adverse Drug Reactions Via Drug Metabolism Studies
Amit Kagutkar
Pfizer Global Research and Development, USA
|
| Discovery Assay by Stage (DABS)
Lawrence Gan
Boehringer-Ingelheim, Germany
|
| Cytochome P450 Dependent Drug Metabolism
and Outcomes of Drug-Drug and Drug-Toxicant Interactions
in Diabetics
Emel Arinc
Professor of Biochemistry and Molecular Biology,
Middle East Technical University, Turkey
|
| Transforming Drug Discovery and Development:
Strategic Application of ADME and Toxicity Testing
Alan G.E. Wilson
Vice President, Drug Metabolism, Pharmacokinetics
and Toxicology, Lexicon Pharmaceuticals, USA
|
| Chimeric Mice with Humanized Liver for
DM Research
Tsuyoshi Yokoi
Professor, Drug Metabolism and Toxicology, Division
of Pharmaceutical Sciences, Graduate School of Medical
Science, Kanazawa University, Japan
|
|
